Unum Therapeutics Inc. (UMRX)

[TFMG]

$UMRX | #UNUM Therapeutics Potential 25% Upside


Nice rally has taken hold post earnings .
Alert is set for break above $3.50
Indicators are in bullish reversal and room to run much higher
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

[byrdiesoccer]

Do not*

[byrdiesoccer]

Do waste your time with that poster. Venrock knows what the F they are doing. This will be a $10 stock before you know it at least

[cjstocksup]

Tell that to all the new major fund holders. Read all the 13g's and form 3's recently and look at the tiny float and OS. No brainer UMRX has been a hold for quite awhile now. The chart has been perfect. It is great for longs and swing traders have had some great swings also.

[surf1944]

Now you may ride it all the way back down!

[cjstocksup]

ROTFLMAO we already rode it up to almost $5.00 from .50. GL with that!

[surf1944]

https://www.stockscores.com/charts/charts/?ticker=UMRX

Open gap on the chart @ .50

[cjstocksup]

I agree and based on the chart and recent huge run we should see UMRX over $5.00 soon.

This one will run very soon. Venrock doesn’t play....

[byrdiesoccer]

This one will run very soon. Venrock doesn’t play....

[cjstocksup]

It was news a few days ago. This bard is not active. Anyone who wanted to sell could have. These are frivolous lawsuits on stocks that run hard. I ignore them they happen on almost all recent hot big board stocks. Just more desperate lawyers. Focus on the real news the 104 million dollar buyout merger that just happened. And all the 13g's. Those are very large investment groups loading up huge on UMRX.

[aljafy]

Why has this not been mentioned?:

https://finance.yahoo.com/news/kaskela-law-llc-announces-investigation-123000510.html

Kaskela Law LLC Announces Investigation of Unum Therapeutics Inc. and Encourages Long-Term Investors to Contact the Firm - UMRX
PR Newswire PR Newswire•July 21, 2020
PHILADELPHIA, July 21, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Unum Therapeutics Inc. (NASDAQ: UMRX) ("Unum" or the "Company") on behalf of the Company's investors.

The investigation seeks to determine whether Unum and/or the Company's officers and directors have violated the securities laws in connection with recent corporate actions, and whether Unum investors have been harmed as a result.

Unum investors are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585, or by email at [e-mail] or online at http://kaskelalaw.com/case/unum-therapeutics-inc/, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740
[e-mail]
www.kaskelalaw.com

[cjstocksup]

I agree. Read all the 13g's lately. Big money has been loading UMRX. Any day now we should run huge above easily over $4.00 to $5.00 IMO. VENROCK takes 5% stake was the last 13g this week.

Follow Venrock money when you can. They loaded heavy in Humanigen as well

[byrdiesoccer]

Follow Venrock money when you can. They loaded heavy in Humanigen as well

[cjstocksup]

$UMRX VENROCK takes 5% stake another big 13 g filed today

[cjstocksup]

UMRX another 13g afterhours today. Could move up big green tomorrow like we did on Friday. The charts so on a $3.50 break we should head to $5.00.

[cjstocksup]

UMRX 104 million dollars on the recent buyout, low SS and float ready for the next leg up IMO over $5.00 and more. We got more filings on this yesterday time to run hard on HUGE volume again refer tot he charts.

Sweet explosion UMRX on news https://finance.yahoo.com/news/unum-therapeutics-inc-announces-acquisition-141600836.html

[cjstocksup]

UMRX moved afterhours I see because of more filings. We got 13g filings. Time to set up the next big run ahead..

[PickleNick]

Right! Amazing play here. Raised over $100M and purchased a therapeutic company in KIQ. Easy play here

[cjstocksup]

UMRX! I agree! $5.00 Monday for UMRX? Shorts have been getting killed daily here, I love it! Pre market this AM at about $4.50 was fun.

[ClayTrader]

* * $UMRX Video Chart 07-10-2020 * *

Link to Video - click here to watch the technical chart video

[PickleNick]

MONSTER!!!!!

[ClayTrader]

* * $UMRX Video Chart 07-07-2020 * *

Link to Video - click here to watch the technical chart video

[wesley_]

$3.08 :D

[PickleNick]

Beautiful

[wesley_]

hod $2.69 what a monster

[ClayTrader]

* * $UMRX Video Chart 07-06-2020 * *

Link to Video - click here to watch the technical chart video

[$treet $inatra]

Sweet explosion UMRX on news https://finance.yahoo.com/news/unum-therapeutics-inc-announces-acquisition-141600836.html

[trendzone]

Today's shorties throw in the pot for lunch, their going to make good chicken soup when fully boiled.

[wesley_]

$2.18 nice runner

[wesley_]

$1.83 sweet

[wesley_]

$1.73 lovely

[wesley_]

$1.42 nice

[swanlinbar]

UMRX they voted on Monday,Anyone know if they are going forward with R/S ? Thanks

[swanlinbar]

UMRX out for now

[swanlinbar]

UMRX-Unum Therapeutics $UMRX Raised to Buy at Zacks Investment Research

[swanlinbar]

UMRX Patience

[swanlinbar]

UMRX-Unum Therapeutics Inc (NASDAQ:UMRX) Receives Consensus Recommendation of “Buy” from Analysts
Posted by ABMN Staff on May 28th, 2020 // No Comments

Unum Therapeutics logoUnum Therapeutics Inc (NASDAQ:UMRX) has earned an average recommendation of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $2.88.

Several equities research analysts have recently weighed in on the stock. Morgan Stanley downgraded shares of Unum Therapeutics from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, March 3rd. Zacks Investment Research raised shares of Unum Therapeutics from a “hold” rating to a “buy” rating and set a $0.50 target price for the company in a research report on Friday, March 6th. Wedbush reissued a “hold” rating and issued a $1.00 target price on shares of Unum Therapeutics in a research report on Sunday, March 29th. Finally, HC Wainwright dropped their target price on shares of Unum Therapeutics from $18.00 to $4.00 and set a “buy” rating for the company in a research report on Friday, March 27th.

[swanlinbar]

UMRX has been Churning here for awhile

[swanlinbar]

[BluSkies]

On watch

[swanlinbar]

UMRX chewing away,little by little imo

[swanlinbar]

UMRX yes waiting on an Update

[swanlinbar]

UMRX need to get by that nut @.58

[Hole shot King]

$UMRX is coming

[swanlinbar]

UMRX could be today

[Hole shot King]

$UMRX twitter

https://twitter.com/unumrx/

[swanlinbar]

UMRX latest Presentation March 2020 https://investors.unumrx.com/static-files/1f2dcf12-9740-4372-8bd3-40a6127a7531

[swanlinbar]

UMRX
https://unumrx.com/

[Hole shot King]

Unum Therapeutics In $UMRX
0.5401 up 0.0403 (8.06%)
Volume: 1,123,922

[swanlinbar]

UMRX Note the level of insider ownership (35%) and recent insider transactions. Note the lack of fluff press releases.)